These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1316770)

  • 21. Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer.
    Rolke HB; Bakke PS; Gallefoss F
    Respir Med; 2008 Oct; 102(10):1460-7. PubMed ID: 18590954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life after different treatment modalities for carcinoma of the oropharynx.
    Tschudi D; Stoeckli S; Schmid S
    Laryngoscope; 2003 Nov; 113(11):1949-54. PubMed ID: 14603054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teniposide in the treatment of small cell lung cancer: a review.
    Hansen HH; Dombernowsky P; Hansen M; Bork E
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):65-8. PubMed ID: 1329227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of Life in a Hospice: A Validation of the Croatian Version of the EORTC QLQ-C15-PAL.
    Golčić M; Dobrila-Dintinjana R; Golčić G; Pavlović-Ružić I; Stevanović A; Gović-Golčić L
    Am J Hosp Palliat Care; 2018 Aug; 35(8):1085-1090. PubMed ID: 29466864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer.
    Manser RL; Wright G; Byrnes G; Hart D; Conron M; Carter R; McLachlan SA; Campbell DA
    Lung Cancer; 2006 Aug; 53(2):217-29. PubMed ID: 16765475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
    Cheng HL; Molassiotis A
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation study of the Thai version.
    Silpakit C; Sirilerttrakul S; Jirajarus M; Sirisinha T; Sirachainan E; Ratanatharathorn V
    Qual Life Res; 2006 Feb; 15(1):167-72. PubMed ID: 16411041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric analysis of a Persian version of the European Organization for Research and Treatment of Cancer OG25 Quality of Life Questionnaire in oesophagogastric cancer patients.
    Hesari AE; Lari MA; Shandiz FH
    Asian Pac J Cancer Prev; 2014; 15(6):2739-45. PubMed ID: 24761894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
    Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
    Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in lung cancer patients: as an important prognostic factor.
    Montazeri A; Milroy R; Hole D; McEwen J; Gillis CR
    Lung Cancer; 2001; 31(2-3):233-40. PubMed ID: 11165402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.
    Beisland E; Aarstad HJ; Aarstad AK; Bakke A; Bostad L; Beisland C
    Acta Oncol; 2016; 55(3):349-56. PubMed ID: 26251300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study Group.
    Helsing M; Bergman B; Thaning L; Hero U
    Eur J Cancer; 1998 Jun; 34(7):1036-44. PubMed ID: 9849452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer.
    Si X; Zhang L; Wang H; Zhang X; Wang M; Han B; Li K; Wang Q; Shi J; Wang Z; Cheng Y; He J; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F; Li B; Chen Y; Zhou J; Wang D
    Lung Cancer; 2018 Aug; 122():32-37. PubMed ID: 30032842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia.
    Ayana BA; Negash S; Yusuf L; Tigeneh W; Haile D
    PLoS One; 2016; 11(6):e0157359. PubMed ID: 27304066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
    Ozturk A; Sarihan S; Ercan I; Karadag M
    Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does knowledge of cancer diagnosis affect quality of life? A methodological challenge.
    Montazeri A; Hole DJ; Milroy R; McEwen J; Gillis CR
    BMC Cancer; 2004 May; 4():21. PubMed ID: 15151702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.